Clinical Trial Update: A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy [Phase 2]

View source ↗

Summary

Clinical trial update indicates a Phase 2 study of YA-101 for multiple system atrophy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• YA-101

Snippet

Sponsor: Dasher Neuroscience Inc. | Conditions: Multiple System Atrophy | Phase 2 | Status: RECRUITING